Fluidigm Developing Cellular Sample Prep Platform for Single-Cell Gene Expression, NGS Studies | GenomeWeb

This article has been updated from a previous version to include market research information about Fluidigm from DeciBio.

Fluidigm disclosed last week that it is developing an automated sample prep system for single-cell gene expression studies and, eventually, single-cell targeted and whole-transcriptome sequencing research.

The South San Francisco, Calif.-based firm also reported that its first-quarter revenues increased 26 percent on strong growth for both its instruments and consumables.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.